Clinical trial
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in…
NCT00316758 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00316758 |
|---|---|
| Title | A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes. |
| Official title | A Multi-center, Open Label, Extension Study to Evaluate the Long-term Safety and Tolerability of GK Activator (2) in Type 2 Diabetic Patients From Studies BM18248 or BM18249 |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus Type 2 |
| Intervention type | Drug |
| Interventions | GK Activator (2), Metformin |
| Enrollment | 259 |
| Start date | Feb 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Apr 21, 2006 |
| Last update posted | Nov 2, 2016 |
| Countries | Australia, Bulgaria, Canada, Croatia, Germany, Guatemala, Hungary, Mexico, Poland, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: